An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer
Clinical trial NCT01661153 · COMPLETED
Trial details
- NCT number
- NCT01661153
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-03-02
- Primary completion
- 2016-09-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.